OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

BACKGROUND: There is uncertainty about the chemotherapy sensitivity of some oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancers. Multiparameter assays that measure the expression of several tumour genes simultaneously have been developed to guide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Technol Assess
Principais autores: Stein, Robert C, Dunn, Janet A, Bartlett, John Ms, Campbell, Amy F, Marshall, Andrea, Hall, Peter, Rooshenas, Leila, Morgan, Adrienne, Poole, Christopher, Pinder, Sarah E, Cameron, David A, Stallard, Nigel, Donovan, Jenny L, McCabe, Christopher, Hughes-Davies, Luke, Makris, Andreas
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781175/
https://ncbi.nlm.nih.gov/pubmed/26867046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta20100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados